Sjögren's syndrome associated with Crohn's disease successfully treated with adalimumab.
Antonio
A
Tursi
D000068879:Adalimumab; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D003424:Crohn Disease / Q000150:complications / Q000188:drug therapy* / Q000276:immunology; D005260:Female; D006801:Humans; D008875:Middle Aged; D012074:Remission Induction; D012859:Sjogren's Syndrome / Q000150:complications / Q000188:drug therapy* / Q000276:immunology
D000893:Anti-Inflammatory Agents; D061067:Antibodies, Monoclonal, Humanized; D000068879:Adalimumab